251 related articles for article (PubMed ID: 8358736)
1. Role of chromosome 9 in human bladder cancer.
Miyao N; Tsai YC; Lerner SP; Olumi AF; Spruck CH; Gonzalez-Zulueta M; Nichols PW; Skinner DG; Jones PA
Cancer Res; 1993 Sep; 53(17):4066-70. PubMed ID: 8358736
[TBL] [Abstract][Full Text] [Related]
2. Evidence for two tumor suppressor loci associated with proximal chromosome 9p to q and distal chromosome 9q in bladder cancer and the initial screening for GAS1 and PTC mutations.
Simoneau AR; Spruck CH; Gonzalez-Zulueta M; Gonzalgo ML; Chan MF; Tsai YC; Dean M; Steven K; Horn T; Jones PA
Cancer Res; 1996 Nov; 56(21):5039-43. PubMed ID: 8895761
[TBL] [Abstract][Full Text] [Related]
3. Frequent association of p53 gene mutation in invasive bladder cancer.
Fujimoto K; Yamada Y; Okajima E; Kakizoe T; Sasaki H; Sugimura T; Terada M
Cancer Res; 1992 Mar; 52(6):1393-8. PubMed ID: 1540947
[TBL] [Abstract][Full Text] [Related]
4. Two molecular pathways to transitional cell carcinoma of the bladder.
Spruck CH; Ohneseit PF; Gonzalez-Zulueta M; Esrig D; Miyao N; Tsai YC; Lerner SP; Schmütte C; Yang AS; Cote R
Cancer Res; 1994 Feb; 54(3):784-8. PubMed ID: 8306342
[TBL] [Abstract][Full Text] [Related]
5. p53 mutations and prognosis in bladder tumors.
Uchida T; Wada C; Ishida H; Wang C; Egawa S; Yokoyama E; Kameya T; Koshiba K
J Urol; 1995 Apr; 153(4):1097-104. PubMed ID: 7869472
[TBL] [Abstract][Full Text] [Related]
6. Improved clonality analysis of multifocal bladder tumors by combination of histopathologic organ mapping, loss of heterozygosity, fluorescence in situ hybridization, and p53 analyses.
Denzinger S; Mohren K; Knuechel R; Wild PJ; Burger M; Wieland WF; Hartmann A; Stoehr R
Hum Pathol; 2006 Feb; 37(2):143-51. PubMed ID: 16426913
[TBL] [Abstract][Full Text] [Related]
7. Clonal origin of lymph node metastases in bladder carcinoma.
Jones TD; Carr MD; Eble JN; Wang M; Lopez-Beltran A; Cheng L
Cancer; 2005 Nov; 104(9):1901-10. PubMed ID: 16196038
[TBL] [Abstract][Full Text] [Related]
8. Frequent loss of heterozygosity on chromosome 10q in muscle-invasive transitional cell carcinomas of the bladder.
Cappellen D; Gil Diez de Medina S; Chopin D; Thiery JP; Radvanyi F
Oncogene; 1997 Jun; 14(25):3059-66. PubMed ID: 9223669
[TBL] [Abstract][Full Text] [Related]
9. Mutation spectrum of the 9q34 tuberous sclerosis gene TSC1 in transitional cell carcinoma of the bladder.
Knowles MA; Habuchi T; Kennedy W; Cuthbert-Heavens D
Cancer Res; 2003 Nov; 63(22):7652-6. PubMed ID: 14633685
[TBL] [Abstract][Full Text] [Related]
10. TP53 alterations as a potential diagnostic marker in superficial bladder carcinoma and in patients serum, plasma and urine samples.
Dahse R; Utting M; Werner W; Schimmel B; Claussen U; Junker K
Int J Oncol; 2002 Jan; 20(1):107-15. PubMed ID: 11743649
[TBL] [Abstract][Full Text] [Related]
11. Molecular genetic alterations of chromosome 17 and p53 nuclear overexpression in human bladder cancer.
Dalbagni G; Presti JC; Reuter VE; Zhang ZF; Sarkis AS; Fair WR; Cordon-Cardo C
Diagn Mol Pathol; 1993 Mar; 2(1):4-13. PubMed ID: 7904525
[TBL] [Abstract][Full Text] [Related]
12. Allelic loss of chromosome 17p distinguishes high grade from low grade transitional cell carcinomas of the bladder.
Olumi AF; Tsai YC; Nichols PW; Skinner DG; Cain DR; Bender LI; Jones PA
Cancer Res; 1990 Nov; 50(21):7081-3. PubMed ID: 2208176
[TBL] [Abstract][Full Text] [Related]
13. Allelic losses of chromosomes 9, 11, and 17 in human bladder cancer.
Tsai YC; Nichols PW; Hiti AL; Williams Z; Skinner DG; Jones PA
Cancer Res; 1990 Jan; 50(1):44-7. PubMed ID: 2293558
[TBL] [Abstract][Full Text] [Related]
14. Homozygous deletion at the 9q32-33 candidate tumor suppressor locus in primary human bladder cancer.
Nishiyama H; Takahashi T; Kakehi Y; Habuchi T; Knowles MA
Genes Chromosomes Cancer; 1999 Oct; 26(2):171-5. PubMed ID: 10469456
[TBL] [Abstract][Full Text] [Related]
15. Loss of heterozygosity at the p53, RB, DCC and APC tumor suppressor gene loci in human bladder cancer.
Miyamoto H; Shuin T; Ikeda I; Hosaka M; Kubota Y
J Urol; 1996 Apr; 155(4):1444-7. PubMed ID: 8632608
[TBL] [Abstract][Full Text] [Related]
16. Molecular genetic alterations in superficial and locally advanced human bladder cancer.
Presti JC; Reuter VE; Galan T; Fair WR; Cordon-Cardo C
Cancer Res; 1991 Oct; 51(19):5405-9. PubMed ID: 1680549
[TBL] [Abstract][Full Text] [Related]
17. Molecular genetic alterations in the laser-capture-microdissected stroma adjacent to bladder carcinoma.
Paterson RF; Ulbright TM; MacLennan GT; Zhang S; Pan CX; Sweeney CJ; Moore CR; Foster RS; Koch MO; Eble JN; Cheng L
Cancer; 2003 Nov; 98(9):1830-6. PubMed ID: 14584063
[TBL] [Abstract][Full Text] [Related]
18. Deletion mapping of chromosome 8 in cancers of the urinary bladder using restriction fragment length polymorphisms and microsatellite polymorphisms.
Knowles MA; Shaw ME; Proctor AJ
Oncogene; 1993 May; 8(5):1357-64. PubMed ID: 8097582
[TBL] [Abstract][Full Text] [Related]
19. P53 mutations as an identification marker for the clonal origin of bladder tumors and its recurrences.
Dahse R; Gärtner D; Werner W; Schubert J; Junker K
Oncol Rep; 2003; 10(6):2033-7. PubMed ID: 14534739
[TBL] [Abstract][Full Text] [Related]
20. Superimposed histologic and genetic mapping of chromosome 17 alterations in human urinary bladder neoplasia.
Chaturvedi V; Li L; Hodges S; Johnston D; Ro JY; Logothetis C; von Eschenbach AC; Batsakis JG; Czerniak B
Oncogene; 1997 May; 14(17):2059-70. PubMed ID: 9160886
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
